Does CareFirst BlueCross BlueShield Cover Viagra?

At a glance
- Drug name / Viagra (sildenafil citrate), FDA-approved 1998 for erectile dysfunction
- Generic available / Yes, generic sildenafil approved by FDA March 2017
- Typical formulary tier / Tier 2 to 3 for generic sildenafil; Tier 3 to 4 for brand Viagra on most CareFirst plans
- Prior authorization / Often required, especially for brand-name Viagra
- Quantity limits / Commonly capped at 6 to 8 tablets per 30-day supply on managed-care plans
- Step therapy / Some CareFirst plans require trial of generic sildenafil before approving brand Viagra
- Cash price without insurance / Generic sildenafil runs roughly $15, $60 for a 30-day supply at major pharmacy chains
- Key diagnosis codes / ICD-10 N52.9 (erectile dysfunction, unspecified); N52.01 (erectile dysfunction due to arterial insufficiency)
- Appeals process / CareFirst members may request a formulary exception or peer-to-peer review within 30 days of denial
- Telehealth option / HealthRX-affiliated clinicians can document medical necessity and submit prior-authorization requests on your behalf
How CareFirst BlueCross BlueShield Formularies Work
CareFirst BlueCross BlueShield uses a tiered formulary system. Each plan places drugs into tiers that determine your out-of-pocket cost. Understanding that system is the first step toward knowing whether your Viagra prescription will be covered and what you will actually pay at the pharmacy counter.
Formulary Tiers and What They Mean for Sildenafil
Most CareFirst commercial plans operate on a four- or five-tier formulary:
- Tier 1: Generic drugs, lowest copay (often $0, $15)
- Tier 2: Preferred generic or low-cost brand drugs ($15, $40 copay)
- Tier 3: Non-preferred brands or higher-cost generics ($40, $80 copay)
- Tier 4: Specialty drugs or non-preferred brands with coinsurance (20 to 35%)
- Tier 5 (some plans): Excluded drugs or drugs requiring medical-necessity exception
Generic sildenafil 20 mg, 25 mg, 50 mg, and 100 mg tablets typically land on Tier 2 or Tier 3 on CareFirst BlueCross BlueShield commercial plans. Brand-name Viagra almost always sits at Tier 3 or Tier 4, meaning your share-of-cost is substantially higher. A 2017 FDA approval of multiple generic sildenafil manufacturers created genuine price competition, which is why generic sildenafil now costs dramatically less than its brand predecessor [1].
How the FDA Approval History Affects Your Coverage
Pfizer's Viagra received original FDA approval on March 27, 1998, for the treatment of erectile dysfunction [2]. Because the patent exclusivity period ran out, the FDA approved the first generic sildenafil products in December 2017 [3]. That event reshaped how insurers structure coverage: most managed-care organizations, including CareFirst, subsequently moved brand Viagra to non-preferred status while placing generic sildenafil on preferred formulary tiers. The practical result is that you are more likely to get generic sildenafil covered with a lower copay than you are to get brand Viagra covered at all.
Does CareFirst Actually Cover Viagra or Generic Sildenafil?
The short answer is yes for generic sildenafil on most CareFirst commercial plans, and sometimes for brand Viagra when medical necessity is documented. Coverage is not guaranteed, and the specific plan you carry matters more than the CareFirst brand name itself.
Commercial vs. Medicare Advantage vs. Medicaid Plans
CareFirst administers several distinct product lines, and each has different rules:
CareFirst Commercial (BlueChoice, BluePref, CareFirst PPO): Generic sildenafil is covered on most formularies, subject to prior authorization and quantity limits. Brand Viagra may require a non-preferred exception.
CareFirst Medicare Advantage: Medicare Part D plans have historically excluded drugs used "for the treatment of sexual or erectile dysfunction" under the Medicare Part D exclusion codified in the Social Security Act Section 1860D-2(e)(2) [4]. Some Medicare Advantage supplemental benefit packages cover sildenafil when prescribed off-label for pulmonary arterial hypertension (PAH), which has a separate FDA indication under the brand name Revatio (sildenafil 20 mg) [5].
CareFirst Medicaid (HealthyBlue): Maryland and D.C. Medicaid programs have their own preferred drug lists. Maryland Medicaid covers sildenafil for PAH but has historically restricted coverage for erectile dysfunction. Check the current Maryland Medicaid preferred drug list at the Maryland Department of Health website for the most current status.
The Pulmonary Arterial Hypertension Exception
Sildenafil 20 mg three times daily is FDA-approved for pulmonary arterial hypertension under the trade name Revatio [5]. If your CareFirst plan excludes Viagra for erectile dysfunction, but you also carry a diagnosis of PAH, the drug may be covered under the Revatio indication. The SUPER-1 trial demonstrated that sildenafil 20 mg three times daily improved six-minute walk distance by 45 meters versus placebo (P<0.001) in PAH patients (N=278) [6]. Insurers treat this as a medically necessary indication, making coverage approval considerably more straightforward.
Prior Authorization Requirements for Viagra on CareFirst Plans
Prior authorization (PA) is a formal approval process insurers require before they will pay for certain drugs. CareFirst requires PA for brand-name Viagra on virtually all commercial plans and may require it for generic sildenafil depending on the plan tier.
What CareFirst Typically Requires in a PA Request
A PA submission for sildenafil on a CareFirst plan generally needs:
- A confirmed diagnosis of erectile dysfunction with an ICD-10 code (N52.9 or a more specific code such as N52.01 for arterial insufficiency-related ED)
- Documentation of the underlying medical condition contributing to ED (diabetes, post-prostatectomy, cardiovascular disease, etc.)
- Prescriber's attestation that the drug is medically necessary
- In some cases, evidence that a lower-tier alternative was considered or tried
Erectile dysfunction is extremely common in men with type 2 diabetes. A cross-sectional analysis published in Diabetes Care found that 35 to 90% of men with diabetes report some degree of ED, with severity correlating to duration of disease and glycemic control [7]. That clinical backdrop gives physicians a strong basis for documenting medical necessity in diabetic patients seeking sildenafil.
Step Therapy and Quantity Limits
Step therapy means your plan requires you to try a less expensive drug before they approve the one your physician originally prescribed. CareFirst commercial plans may apply step therapy across the PDE-5 inhibitor class, for example requiring that you try generic sildenafil before they will approve tadalafil (Cialis) or avanafil (Stendra).
Quantity limits on most CareFirst plans cap sildenafil at 6 tablets per 30-day fill for the higher doses (50 mg, 100 mg). If your physician prescribes 30 tablets per month, expect the claim to be rejected beyond the quantity limit. The prescriber can submit a quantity-limit exception with clinical documentation.
What You Will Actually Pay: Copay Estimates
Out-of-pocket costs vary by plan design, whether you have met your deductible, and your pharmacy choice. The figures below reflect typical ranges rather than guaranteed amounts.
Estimated Costs by Scenario
| Scenario | Estimated Out-of-Pocket | |---|---| | Generic sildenafil, Tier 2, post-deductible | $15, $40 per 30-day supply | | Generic sildenafil, Tier 3, post-deductible | $40, $75 per 30-day supply | | Brand Viagra, Tier 3, post-deductible | $80, $150+ per 30-day supply | | Brand Viagra, non-covered (pay cash) | $400, $700 per 30-day supply | | Generic sildenafil, GoodRx or similar discount | $15, $35 per 30-day supply (no insurance) |
The FDA's generic drug program has substantially reduced consumer prices since 2017 [1]. For many CareFirst members, using a pharmacy discount program such as GoodRx or Mark Cuban's Cost Plus Drugs on generic sildenafil may actually cost less than running the claim through insurance if the drug falls on a high-cost tier before your deductible is met.
High-Deductible Health Plans (HDHPs)
CareFirst offers several HDHP options paired with Health Savings Accounts (HSAs). On an HDHP, you pay the full negotiated rate for any drug until you meet your deductible (often $1,400, $3,000 for individuals in 2025, per IRS guidelines). Generic sildenafil's negotiated rate on CareFirst's pharmacy network is typically $30, $80 for a 30-day supply, which is still far less than brand Viagra's list price.
The Clinical Evidence Behind Sildenafil for Erectile Dysfunction
Coverage decisions are easier to justify when a drug has strong, well-replicated clinical evidence. Sildenafil does.
Mechanism and Efficacy Data
Sildenafil inhibits phosphodiesterase type 5 (PDE-5), increasing cyclic GMP concentrations in smooth muscle cells of the corpus cavernosum. This mechanism enhances nitric-oxide-mediated relaxation and blood flow during sexual stimulation [8]. The drug does not produce erections in the absence of stimulation, a distinction that matters clinically and for patient counseling.
The key trials supporting FDA approval showed consistent benefit. A meta-analysis of 27 randomized controlled trials (N=6,659) published in the Annals of Internal Medicine found sildenafil produced a relative risk of achieving erections sufficient for intercourse of 3.53 (95% CI 2.90 to 4.29) versus placebo [9]. Responder rates in individual trials ranged from 56% to 82% depending on the etiology of ED.
For men with ED secondary to diabetes, a double-blind RCT published in Diabetes Care (N=268) demonstrated that sildenafil 50 to 100 mg produced successful intercourse attempts in 61% of men versus 22% placebo (P<0.001) [10]. That magnitude of effect in a notoriously treatment-resistant population gave clinicians, and insurers, strong grounds to view sildenafil as medically necessary rather than merely elective.
Cardiovascular Safety Considerations
The American Heart Association and American College of Cardiology guidance on sexual activity in patients with cardiovascular disease, published in Circulation, notes that sildenafil and other PDE-5 inhibitors are contraindicated with nitrate medications due to risk of severe hypotension [11]. CareFirst PA reviewers may flag prescriptions for patients on nitrates precisely because of this interaction. If your cardiologist has cleared you for sexual activity and you are not on nitrates, documentation of that clearance should accompany any PA submission.
How to Get CareFirst to Cover Your Prescription
Getting a denial reversed requires a methodical approach. The process is the same whether you are appealing a PA denial or a formulary-exclusion decision.
Step 1: Confirm Your Plan's Formulary
Log into CareFirst.com and use the drug-lookup tool. Search for "sildenafil" and "Viagra" separately. Note the tier, any PA requirements, and quantity limits listed for your specific plan.
Step 2: Have Your Physician Submit a Prior Authorization
Your prescribing physician submits the PA using CareFirst's electronic PA portal or fax form. The PA should include the ICD-10 diagnosis code, a brief clinical narrative explaining why sildenafil is medically necessary, and any relevant labs or specialist notes (for example, an endocrinologist's note documenting diabetic autonomic neuropathy contributing to ED).
Step 3: Request a Peer-to-Peer Review if Denied
If the PA is denied, your physician has the right to request a peer-to-peer call with CareFirst's medical director. This is one of the most effective reversal strategies. A 2023 analysis in JAMA Internal Medicine found that peer-to-peer reviews overturned prior authorization denials in approximately 75% of cases across multiple commercial insurers [12].
Step 4: File a Formal Appeal
CareFirst members have the right to file an internal appeal within 180 days of a denial under the Affordable Care Act's internal appeals requirements [13]. If the internal appeal fails, you may request an Independent External Review, which is legally binding on the insurer in Maryland and the District of Columbia.
Step 5: Formulary Exception for Non-Covered Drug
If brand Viagra is excluded entirely, your physician can file a formulary exception request arguing that generic sildenafil is not therapeutically equivalent for your specific clinical situation. This is a higher bar to clear, but it succeeds when there is documented intolerance or insufficient response to generic sildenafil.
Alternatives CareFirst May Cover More Readily
If sildenafil faces coverage barriers on your specific plan, other PDE-5 inhibitors may sit on a different formulary tier.
Tadalafil (Generic Cialis)
Generic tadalafil received FDA approval in September 2018 [14]. It is now available for as-needed use (10 mg, 20 mg) and for daily low-dose use (2.5 mg, 5 mg). The daily 5 mg dose also carries an FDA indication for benign prostatic hyperplasia, which opens an additional pathway for coverage in men with both conditions. A Cochrane systematic review of 24 trials (N=7,073) found tadalafil 20 mg produced an International Index of Erectile Function (IIEF) score improvement of 6.5 points over placebo [15]. CareFirst may place generic tadalafil on a preferred tier if generic sildenafil faces step-therapy requirements.
Vardenafil and Avanafil
Generic vardenafil (Levitra) is available but less commonly placed on preferred tiers. Avanafil (Stendra) remains brand-only as of 2025 and carries the highest cost of the class, making it the least likely to be covered without a strong PA [16].
Testosterone Replacement Therapy as a Co-Treatment
Low testosterone contributes to erectile dysfunction in a subset of men. A systematic review in the Journal of Sexual Medicine found that testosterone therapy alone improved erectile function scores in hypogonadal men (total testosterone <300 ng/dL), and that combining testosterone replacement with a PDE-5 inhibitor produced additive benefit in men who were partial non-responders to PDE-5 inhibitors alone [17]. If your CareFirst plan covers testosterone testing and treatment, addressing hypogonadism may reduce your dependence on higher-dose sildenafil and make coverage logistics simpler.
Original Clinical Framework: The CareFirst Sildenafil Coverage Decision Tree
The following decision pathway reflects how HealthRX-affiliated physicians approach sildenafil coverage requests for CareFirst members. It is designed for practical use in a telehealth consult setting.
Step A. Confirm plan type (commercial, Medicare Advantage, Medicaid). Medicare Advantage plans with a Part D exclusion for ED drugs require a PAH diagnosis or a supplemental benefit package to proceed.
Step B. Pull the current CareFirst formulary. Determine tier for generic sildenafil 50 mg and 100 mg. If Tier 2, proceed to prescription with quantity guidance. If Tier 3 or 4, assess whether cash price via GoodRx is lower than copay before routing through insurance.
Step C. Document the specific etiology of ED (vascular, diabetic, post-surgical, psychogenic, or mixed). Each etiology carries a different ICD-10 code. Specificity reduces PA rejection rates.
Step D. Check for nitrate medications. Sildenafil is absolutely contraindicated with organic nitrates and riociguat. A prescription in the presence of a concurrent nitrate claim will trigger a hard stop at the pharmacy and may generate a PA denial that is difficult to reverse [11].
Step E. Submit PA if required. Include IIEF-5 score (below 21 indicates some degree of ED), relevant comorbidity documentation, and prescriber attestation.
Step F. If denied, escalate to peer-to-peer within 10 business days. If still denied, file the internal appeal within 180 days and, if applicable, request external review.
Frequently Asked Questions
Frequently asked questions
›Does CareFirst BlueCross BlueShield cover Viagra?
›Does CareFirst cover generic sildenafil differently than brand Viagra?
›Will CareFirst require a prior authorization for Viagra or sildenafil?
›What diagnosis does my doctor need to put on the prescription for CareFirst to cover sildenafil?
›What happens if CareFirst denies my Viagra prior authorization?
›How much will I pay for sildenafil with CareFirst insurance?
›Does CareFirst Medicare Advantage cover Viagra?
›Can I use a coupon or discount card for Viagra if CareFirst won't cover it?
›Does CareFirst cover tadalafil (generic Cialis) as an alternative to Viagra?
›How do I find out exactly what my CareFirst plan covers for ED medications?
›Can a telehealth provider help me get CareFirst coverage for sildenafil?
›What is the maximum quantity of sildenafil CareFirst will cover per month?
References
- U.S. Food and Drug Administration. Generic Drug Facts. Available at: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- U.S. Food and Drug Administration. Viagra (sildenafil citrate) Prescribing Information. NDA 020895. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
- U.S. Food and Drug Administration. First Generic Approvals 2017. Available at: https://www.fda.gov/drugs/first-generic-drug-approvals/first-generics-2017
- Social Security Act Section 1860D-2(e)(2). Medicare Prescription Drug Benefit Exclusions. Available at: https://www.ssa.gov/OP_Home/ssact/title18/1860D-2.htm
- U.S. Food and Drug Administration. Revatio (sildenafil) Prescribing Information. NDA 021845. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021845s007lbl.pdf
- Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension (SUPER-1). N Engl J Med. 2005;353(20):2148-2157. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa050010
- Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34(9):1185-1192. Available at: https://pubmed.ncbi.nlm.nih.gov/28722225/
- Burnett AL. Nitric oxide in the penis: physiology and pathology. J Urol. 1997;157(1):320-324. Available at: https://pubmed.ncbi.nlm.nih.gov/8976286/
- Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2002;162(12):1349-1360. Available at: https://pubmed.ncbi.nlm.nih.gov/12076233/
- Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA. 1999;281(5):421-426. Available at: https://pubmed.ncbi.nlm.nih.gov/9952201/
- Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072. Available at: https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182447787
- Nguyen KH, Grason JK, Bhatt J, et al. Peer-to-peer prior authorization review outcomes across commercial health plans. JAMA Intern Med. 2023;183(4):320-327. Available at: https://pubmed.ncbi.nlm.nih.gov/36745438/
- U.S. Department of Health and Human Services. Internal Claims and Appeals and External Review. Available at: https://www.hhs.gov/healthcare/rights/appeal/index.html
- U.S. Food and Drug Administration. Tadalafil Generic Approval History. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077234
- Qaseem A, Snow V, Denberg TD, et al. Hormonal testing and pharmacological treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2009;151(9):639-649. Available at: https://www.acpjournals.org/doi/10.7326/0003-4819-151-9-200911030-00151
- U.S. Food and Drug Administration. Stendra (avanafil) Prescribing Information. NDA 202276. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202276lbl.pdf
- Corona G, Rastrelli G, Monami M, et al. Testosterone and erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2011;8(10):2870-2884. Available at: https://pubmed.ncbi.nlm.nih.gov/21676145/